Agomelatine SPC
The Summary of Product Characteristics for agomelatine (Valdoxan®) is now available via the electronic Medicines Compendium (eMC).
As previously discussed, agomelatine is a new class of antidepressant. The SPC gives more details for this drug including known side effects, precautions and interactions.
Action: Clinicians who are considering using this new drug would be wise to review the SPC before starting a treatment.
| « Swine 'flu pandemic declared | Minodiab 2.5mg discontinued » |
Leave a Comment